Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Electroconvulsive Therapy01:30

Electroconvulsive Therapy

Electroconvulsive therapy (ECT), or shock therapy, remains a critical biomedical intervention for severe, treatment-resistant depression. While its origins can be traced back to Hippocrates' observations that malaria-induced convulsions alleviated mental illness, modern ECT has evolved significantly from its earlier, more primitive applications. First introduced in 1938 by Ugo Cerletti and his colleagues, ECT involves inducing controlled seizures using electrical currents. In its early years,...
Mania and Antimanic Drugs: Overview01:24

Mania and Antimanic Drugs: Overview

Mania, a psychological condition characterized by elevated mood, increased energy, and reduced sleep need, is part of the bipolar disorder cycle. The exact cause of mania isn't entirely known, but it is thought to be a combination of genetic, environmental, and neurological factors. Bipolar disorder involves alternating manic and depressive episodes. Mood stabilizers like lithium, antipsychotics, and anticonvulsants help manage these episodes. Lithium carbonate is particularly effective as a...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

A Global Delphi-Based Expert Consensus on Relapse Prevention Strategies Following Successful Electroconvulsive Therapy for Major Depressive Disorder.

The American journal of psychiatry·2026
Same author

Development and validation of the NIMHANS-NMHS-2 disability scale (NNDS).

Indian journal of psychiatry·2026
Same author

The battle within: Interplay of defeatist beliefs and self-stigma in schizophrenia.

Asian journal of psychiatry·2026
Same author

Does improvement in attention through theta/beta neurofeedback training result in better entry-level vocational task performance in individuals with schizophrenia? An open-label randomised controlled trial.

Asian journal of psychiatry·2026
Same author

Aberrant motor cortical plasticity in antipsychotic-resistant schizophrenia: A cross-sectional study using transcranial direct current and magnetic stimulation.

Schizophrenia research·2026
Same author

Low Treatment Gap for Schizophrenia in Rural India: A Step Toward Taluk Mental Health Program.

Indian journal of psychological medicine·2026

Related Experiment Video

Updated: Jun 10, 2026

Pupillary Response as Assessment of Effective Seizure Induction by Electroconvulsive Therapy
04:51

Pupillary Response as Assessment of Effective Seizure Induction by Electroconvulsive Therapy

Published on: April 11, 2019

A prospective comparative study of interaction between lithium and modified electroconvulsive therapy.

Jagadisha Thirthalli1, Thippeswamy Harish, Bangalore N Gangadhar

  • 1Department of Psychiatry, National Institute of Mental Health and Neuro Sciences, Bangalore, India. jagatth@yahoo.com

The World Journal of Biological Psychiatry : the Official Journal of the World Federation of Societies of Biological Psychiatry
|July 22, 2010
PubMed
Summary

Concurrent lithium use with electroconvulsive therapy (ECT) is generally safe, with lower cardiovascular responses observed. Maintaining lower serum lithium levels is recommended for patients undergoing ECT, particularly younger individuals without ECT risk factors.

Related Experiment Videos

Last Updated: Jun 10, 2026

Pupillary Response as Assessment of Effective Seizure Induction by Electroconvulsive Therapy
04:51

Pupillary Response as Assessment of Effective Seizure Induction by Electroconvulsive Therapy

Published on: April 11, 2019

Area of Science:

  • Neuroscience
  • Psychiatry
  • Pharmacology

Background:

  • Electroconvulsive therapy (ECT) is a vital treatment for severe psychiatric disorders.
  • Lithium is a common mood stabilizer used in conjunction with ECT.
  • Understanding potential interactions between lithium and ECT is crucial for patient safety.

Purpose of the Study:

  • To compare adverse effects in patients receiving ECT with and without concurrent lithium treatment.
  • To evaluate the safety and efficacy of combined lithium and ECT therapy.

Main Methods:

  • A comparative study of inpatients undergoing ECT, divided into lithium (n=27) and non-lithium (n=28) groups.
  • Clinicians, blinded to lithium status, assessed seizure parameters, cardiovascular response, and recovery.
  • Data collected included seizure variables, apnea time, cardiovascular response, and post-ECT complications.

Main Results:

  • No significant differences were found in seizure variables, apnea time, or anesthetic recovery between groups.
  • Patients on combined lithium and ECT exhibited significantly lower maximum heart rate, systolic blood pressure, and rate pressure product.
  • A direct correlation was observed between serum lithium levels and the time to post-ECT recovery in lithium-treated patients.

Conclusions:

  • Concurrent lithium administration during ECT is largely safe.
  • Maintaining serum lithium levels at the lower end of the therapeutic range is beneficial.
  • Findings are most applicable to younger patients without pre-existing ECT risk factors.